Correlations of complete blood count, liver enzyme and serum uric Acid in Sudanese pre-eclamptic cases


  • Hind M. Beheiry
  • Ibrahim A. Ali Department of Physiology, Faculty of Medicine, The National Ribat University, Khartoum, Sudan
  • Mazin S. Abdalla Department of physiology, Faculty of Medicine, Napata College, Khartoum, Sudan
  • Ahmed M. Sharif Department of Medicine, Faculty of Medicine, University of Khartoum, Khartoum, Sudan
  • Amal M. Saeed Department of Medicine, Faculty of Medicine, University of Khartoum, Khartoum, Sudan



ALT, AST, CBC, Liver enzymes, Pre-eclampsia


Background: Pre-eclampsia is a serious disorder of pregnancy with unknown ethological factors that may occur at any stage of second or third trimester of pregnancy. The objectives of the present study were to assess changes in complete blood counts including platelets, liver enzymes and serum uric acid in pre-eclamptic cases compared to second-half normal pregnant and non-pregnant Sudanese women and their correlations to other biomarkers.

Methods: This was a cross-sectional, case-control study performed from December 2008 to December 2010; in Omdurman Maternity Hospital, in concomitance with other studies in pre-eclampsia. The sample size included three groups, 72 up pre-eclamptic cases in their recent pregnancies, 96 normal pregnant in their second half of pregnancy and 63 non- pregnant (control) women; a total of 231 subjects. Questionnaire Interviews and clinical examination were done for all participants. Laboratory investigations were done including complete blood picture, liver enzymes and uric acid.  

Results: The mean Hb concentration of the pre-eclamptic (11.3g/dl±1.7) was statistically significantly lower than that of the non-pregnant (12.1g/dl±0.2) (P=0.01) but not from that of the normal pregnant (11.4g/dl±0.1) (P=0.882) .There was no statistical significant difference in the mean WBC count between the pre-eclamptic (7.4x103/mm3±0.3) and non-pregnant (7.3x103/mm3±0.3) (P=0.797) and between the pre-eclamptic and normal pregnant (7.7x103/mm3±0.2) (P=0.270). There was a considerable statistical significant decrease in the mean platelets count of the pre-eclamptic (236.4/mm3±8.3) compared to the non-pregnant group (322.0/mm3±10.4) (P=0.0001) s well as to the normal pregnant (275.0/mm3±8.9) (P = 0.003). In the pre-eclamptic cases, serum ALT correlated significantly with TWCC (r=0.26, P=0.03) and serum AST (r=0.65, P=0.000). In the pre-eclamptic cases, serum AST correlated significantly with Hb (r=0.26, P=0.03), serum ALT and serum uric acid (r=0.36, P=0.01).

Conclusions: There was a considerable statistical significant decrease in mean platelets count of the pre-eclamptic compared to the non-pregnant group and to the normal pregnant may be explained by hemodilution; whereas further decrease was due to pre-eclampsia. ALT and AST are strong prognostic indicators of pre-eclampsia.


Mashiloane CD, Moodley J. Induction or Caesarean section for pre-term preeclampsia. J Obstet Gynecol. 2002;22(4):353-6.

American College of Obstetricians and Gynecologists. Diagnosis and management of preeclampsia and eclampsia. ACOG Practice Bulletin No.33. Obstet Gynecol. 2002;99:159-67. (Level III)

Reports of the National High Blood Pressure Education Program Working Group report on high blood pressure in Pregnancy. Am J Obstet Gynecol. 2000;183:S1-S22.

Cunningham FG, Leveno KJ, Bloom SL, Hauth JC, Rouse DJ, Spong CY. Williams Obstetrics 23rd Ed. New York: McGraw-Hill 2010;706-56.

Sibai, Dekkar G, Kupferminc M. Preeclampsia. Lancet. 2005;365(9461):785-99.

Duha D, Konar H. Textbook of Obstetrics Including Perinatology and Contraception.5th ed. Culcutta: New Central Book Agency (p) ltd. 2001;234-55.

Bellamy L, Casas JP, Hingorani AD, Williams DJ. Preeclampsia and Risk of Cardiovascular Disease and Cancer in Later Life: Systematic Review and Meta-analysis. Obstet Anesth Digest. 2008;28(2):80.

Soloman CG, Seely EW. Preeclampsia-Searching for the cause. N Eng J Med. 2004;350(7):641-12.

Irgens HU, Roberts JM, Reisæter L, Irgens LM, Lie RT. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study Pre-eclampsia and cardiovascular disease later in life: who is at risk? BMJ. 2001;323(7323):1213-7.

Bonnar J, Mcnicol GP, Douglas AS. Mean platelet and red cell volume measurement to estimate the severity of hypertension in pregnancy. Br. M Journal. 1971;2:12.

Shehata N, Burrows R, Kelton JG. Gestational thrombocytopenia. Clin Obstet Gynecol. 1999;42:327-34.

Redman CWG, Bonnar J, Beilin L. Early platelet consumption in preeclampsia. BMJ. 1978;1:467-9.

Sibai BM, Caritis S, Hauth J. What we have learned about preeclampsia. Semin Perinatol. 2003;27(3):239-46.

Lindheimer MD, Taler SJ, Cunningham FG. Hypertension in pregnancy. J Am Soc Hypertens. 2008;2(6):484-94.

American College of Obstetricians and Gynecologists (ACOG) Practice bulletin: Diagnosis and management of preeclampsia and eclampsia. Obstet Gynecol. 2002;99(1):159-67.

Rath W, Fischer T. The diagnosis and treatment of hypertensive disorders of pregnancy: New findings for the antenatal and inpatient care. Dtsch Arztebl Int. 2009;106(45):733-8.

Hasanzadeh M, Ayatollahi H, Farzadnia M, Ayati S, Khoob MK. Elevated plasma total homocysteine in preeclampsia. Saudi Med J. 2008;29:875-8.

Vahidroudsari F, Ayati S, Torabizadeh A, Ayatollahi H, Esmaeli H, Shahabian M. Serum calcium and magnesium concentration in preeclamptic and normal pregnancies; a comparative study. J Reprod Infertil. 2008;9:256-62.

Hladunewich M, Karumanchi SA, Lafayette R. Pathophysiology of the clinical manifestations of preeclampsia. Clin J Am Soc Nephrol. 2007;2(3):543-9

Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005;308(5728):1592-4.

Beheiry HM, Rayis DR, Elzibair AM, Omer MI, Makwana P, Saeed AM. Evaluation of Serum Cystatin C as an Indicator of Glomerular Filtration Rate and its Correlations to other Biomarkers in Detection of Pre-eclampsia. J Afr Ass Physiol. Sci.2015;3(2)199-206.






Original Research Articles